Clinical Trials Browser

Phase 2 × Neutropenia × Breast × Clear all

NCT07380646 2026-02-02

the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms, Leukopenia, Neutropenia

NCT02685111 2020-07-31

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

Phase 2 Terminated

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT03251768 2019-09-13

Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients

Phase 2 Completed

Breast Neoplasms, Neutropenia

NCT01648322 2018-10-03

Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Phase 2 Completed

232 enrolled 19 charts

Breast Neoplasms, Neutropenia

NCT02005458 2018-07-17

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy

Phase 2 Completed

BreastClassical hematologyThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neutropenia, Febrile Neutropenia

NCT01569087 2016-12-05

Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer

Phase 2 Completed

60 enrolled 17 charts

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT02778763 2016-07-20

Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis

Phase 2 Completed

Breast Neoplasms, Neutropenia

NCT02119715 2014-04-22

A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy

Phase 2 Completed

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT00771433 2011-05-13

G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer

Phase 2 Completed

Breast Neoplasms, Neutropenia

NCT00497809 2011-05-03

Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia

Phase 2 Completed

Breast Neoplasms, Neutropenia

NCT00124111 2010-02-26

A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

Phase 2 Completed

Breast Neoplasms, Neoplasms, Neutropenia

NCT00115414 2008-08-01

Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)

Phase 2 Completed

Breast Neoplasms, Fever, Neutropenia

NCT00501332 2007-12-24

Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy

Phase 2 Unknown

Breast Neoplasms, Neoplasms, Neutropenia